Harel Insurance Investments & Financial Services Ltd. Indaptus Therapeutics, Inc. Transaction History
Harel Insurance Investments & Financial Services Ltd.
- $5.8 Billion
- Q3 2024
Shares
4 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
605KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$215,2620.0% of portfolio
-
Investment House LLC Las Vegas, NV100KShares$83,9790.01% of portfolio
-
Geode Capital Management, LLC Boston, MA73.1KShares$61,4280.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$38,0820.01% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44KShares$36,9450.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $6.94M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...